Kyle Elrod

Design of a SARS-CoV-2 papain-like protease inhibitor with antiviral efficacy in a mouse model

Computational approaches streamlining drug discovery

A novel serine protease inhibition motif involving a multi-centered short hydrogen bonding network at the active site11Edited by D. Rees

Engineering inhibitors highly selective for the S1 sites of Ser190 trypsin-like serine protease drug targets